Gyre Therapeutics Inc. (GYRE) — Net Asset Momentum
Gyre Therapeutics Inc. (GYRE) recorded a net asset momentum of 44.6% as of December 2025, with net assets of $142.28 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check GYRE goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
Gyre Therapeutics Inc. Net Asset Momentum (2002–2025)
This chart tracks Gyre Therapeutics Inc.'s year-over-year net asset growth across 24 annual reporting periods from 2002 to 2025. The most recent momentum reading is +44.6%, with net assets of $142.28 Million USD as of December 2025. Read Gyre Therapeutics Inc. balance sheet liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Gyre Therapeutics Inc. (2002–2025)
The table below shows the complete annual net asset history for Gyre Therapeutics Inc. from 2002 to 2025, covering 24 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see GYRE stock market capitalisation.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $142.28 Million | $166.13 Million | $23.85 Million | ▲ +44.6% |
| 2024 | $98.40 Million | $125.41 Million | $27.00 Million | ▲ +605.4% |
| 2023 | $13.95 Million | $116.54 Million | $102.59 Million | ▼ -80.7% |
| 2022 | $72.22 Million | $84.75 Million | $12.54 Million | ▲ +75.8% |
| 2021 | $41.09 Million | $55.66 Million | $14.57 Million | ▼ -46.0% |
| 2020 | $76.07 Million | $94.85 Million | $18.78 Million | ▲ +11.3% |
| 2019 | $68.34 Million | $98.55 Million | $30.22 Million | ▼ -43.0% |
| 2018 | $119.94 Million | $124.92 Million | $4.97 Million | ▲ +289.8% |
| 2017 | $30.77 Million | $39.51 Million | $8.74 Million | ▲ +91.5% |
| 2016 | $16.07 Million | $38.09 Million | $22.02 Million | ▼ -48.9% |
| 2015 | $31.43 Million | $69.52 Million | $38.10 Million | ▼ -71.2% |
| 2014 | $109.08 Million | $112.00 Million | $2.91 Million | ▼ -19.0% |
| 2013 | $134.61 Million | $145.87 Million | $11.26 Million | ▼ -23.5% |
| 2012 | $175.91 Million | $189.58 Million | $13.66 Million | ▲ +0.9% |
| 2011 | $174.29 Million | $258.13 Million | $83.84 Million | ▲ +89.8% |
| 2010 | $91.85 Million | $262.79 Million | $170.94 Million | ▲ +33.1% |
| 2009 | $68.99 Million | $319.38 Million | $250.39 Million | ▲ +20.2% |
| 2008 | $57.37 Million | $98.55 Million | $41.18 Million | ▲ +11.2% |
| 2007 | $51.58 Million | $98.96 Million | $47.38 Million | ▼ -20.6% |
| 2006 | $65.00 Million | $81.37 Million | $16.37 Million | ▲ +140.0% |
| 2005 | $-162.48 Million | $28.00 Million | $190.48 Million | ▼ -32.1% |
| 2004 | $-122.97 Million | $58.20 Million | $181.17 Million | ▼ -367.7% |
| 2003 | $45.93 Million | $47.39 Million | $1.46 Million | ▼ -12.2% |
| 2002 | $52.29 Million | $54.38 Million | $2.09 Million | — |